Skip to content

A long-term real-world cohort study of airborne allergen immunotherapy

A long-term real-world cohort study of airborne allergen immunotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118779
Enrollment
Unknown
Registered
2026-02-10
Start date
2026-02-10
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Allergen immunotherapy group:None
Control group:None

Sponsors

Chinese Academy of Medical Sciences, Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 5 years old; 2. Meet the diagnostic criteria for allergic rhinitis or allergic asthma; 3. The serum sIgE levels of one or more types of airborne allergens such as dust mites, pollen, molds, animal dander, cockroaches, etc. are >= level 1.

Exclusion criteria

Exclusion criteria: Unable to cooperate with the follow-up

Design outcomes

Primary

MeasureTime frame
Combined symptom-medication score;

Secondary

MeasureTime frame
Adverse reaction;Immunoglobulin subclasses, allergen-specific IgE inhibition test, lymphocyte subset detection, IgE mRNA display technology;Visual Analogue scale;Allergen-specific IgE inhibition test;Lymphocyte subset detection;IgE mRNA Display Technology;Quality of life score for rhinoconjunctivitis;

Countries

China

Contacts

Public ContactGuan Kai;Pan Zhouxian

Chinese Academy of Medical Sciences, Peking Union Medical College Hospital

dr_guankai@126.com+86 10 6915 1601

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026